We have located links that may give you full text access.
Impact of stop β interferon on 20 cases of relapsing remitting multiple sclerosis in BMC Benghazi-Libya 2011.
Multiple Sclerosis and related Disorders 2014 November
BACKGROUND: Multiple sclerosis is a common demylinating and inflamatory disease of the CNS with a presumed autoimmune etiology. Interferon β have been used for relapsing remitting multiple sclerosis through its regulatory properties on T-cell activation and cytokines production.
OBJECTIVES: During the war Benghazi-Libya (17 February 2011 revolution) multiple sclerosis patients have got stopped β interferon because unavailability of drugs which allow to evaluate the efficacy of β interferon on relapsing remitting multiple sclerosis regarding frequency and severity of relapses during months of stopping it.
METHODS: Twenty cases of relapsing remitting multiple sclerosis aged 18-55 years of disease duration 1-11 years were on βinterferon none of them have a relapse studied in comparative retrospective prospective study disease relapse, none of the patients has relapse, no relapse, its severity, nature of relapse and respond to Rx in months of stoppage of β interferon and before stop it using frequency, percentage and P value.
RESULTS: Fifteen cases of 20 got relapse (75% relapse rate) significant rate, 3 cases have more than 1 relapse, 12 got severe relapse, 11 cases admitted to hospital, all patients recieved Methylprednisolone 1g (3-5 days), 13 got complete respond and 2 incomplete.
CONCLUSION: β Interferon is efficient in prevention of relapse and decreasing severity of relapse in relapsing remitting multiple sclerosis.
OBJECTIVES: During the war Benghazi-Libya (17 February 2011 revolution) multiple sclerosis patients have got stopped β interferon because unavailability of drugs which allow to evaluate the efficacy of β interferon on relapsing remitting multiple sclerosis regarding frequency and severity of relapses during months of stopping it.
METHODS: Twenty cases of relapsing remitting multiple sclerosis aged 18-55 years of disease duration 1-11 years were on βinterferon none of them have a relapse studied in comparative retrospective prospective study disease relapse, none of the patients has relapse, no relapse, its severity, nature of relapse and respond to Rx in months of stoppage of β interferon and before stop it using frequency, percentage and P value.
RESULTS: Fifteen cases of 20 got relapse (75% relapse rate) significant rate, 3 cases have more than 1 relapse, 12 got severe relapse, 11 cases admitted to hospital, all patients recieved Methylprednisolone 1g (3-5 days), 13 got complete respond and 2 incomplete.
CONCLUSION: β Interferon is efficient in prevention of relapse and decreasing severity of relapse in relapsing remitting multiple sclerosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app